TP53 and colorectal carcinoma: We show that the combined application of irinotecan and entinostat synergistically kills CRC cells in vitro and in vivo and that the induction of C‐terminal hyperacetylation of p53 is an absolute requirement for apoptosis induction by irinotecan and entinostat.